Alvin E. Davis

6.1k total citations
105 papers, 4.9k citations indexed

About

Alvin E. Davis is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Alvin E. Davis has authored 105 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Genetics, 44 papers in Hematology and 43 papers in Immunology. Recurrent topics in Alvin E. Davis's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (70 papers), Complement system in diseases (35 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). Alvin E. Davis is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (70 papers), Complement system in diseases (35 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). Alvin E. Davis collaborates with scholars based in United States, Australia and United Kingdom. Alvin E. Davis's co-authors include Fengxin Lu, Jennifer Scafidi, Pedro Mejia, Karen Binkley, R. A. Harrison, Ryan C. MacFarlane, Fred S. Rosen, Shenghe Cai, Marco Cicardi and Kulwant S. Aulak and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Alvin E. Davis

104 papers receiving 4.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Alvin E. Davis	2.7k	1.8k	1.5k	942	917	105	4.9k
Anette Bygum	2.1k 0.8×	624 0.3×	618 0.4×	904 1.0×	635 0.7×	230	4.1k
Margarita López‐Trascasa	1.3k 0.5×	3.5k 1.9×	1.8k 1.1×	546 0.6×	328 0.4×	126	4.9k
J Breton-Gorius	1.3k 0.5×	1.1k 0.6×	3.6k 2.3×	1.2k 1.3×	160 0.2×	112	5.6k
Maurice G. Colomb	914 0.3×	1.7k 0.9×	1.1k 0.7×	739 0.8×	168 0.2×	100	3.3k
Paschalis Sideras	1.5k 0.5×	4.8k 2.6×	812 0.5×	1.8k 1.9×	68 0.1×	79	7.3k
Shirou Fukuhara	627 0.2×	2.9k 1.6×	1.1k 0.7×	1.6k 1.7×	64 0.1×	143	5.7k
Eric Eldering	2.5k 0.9×	2.5k 1.3×	1.0k 0.7×	2.2k 2.3×	155 0.2×	170	6.0k
P J Lachmann	548 0.2×	1.8k 1.0×	840 0.5×	543 0.6×	166 0.2×	76	2.9k
Kazuya Shimoda	1.3k 0.5×	2.9k 1.6×	1.6k 1.0×	1.9k 2.0×	70 0.1×	250	6.4k
Debra D. Pittman	1.1k 0.4×	1.2k 0.7×	2.6k 1.7×	1.4k 1.5×	85 0.1×	85	5.3k

Countries citing papers authored by Alvin E. Davis

Since Specialization

Citations

This map shows the geographic impact of Alvin E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alvin E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alvin E. Davis more than expected).

Fields of papers citing papers by Alvin E. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alvin E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alvin E. Davis. The network helps show where Alvin E. Davis may publish in the future.

Co-authorship network of co-authors of Alvin E. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Alvin E. Davis. A scholar is included among the top collaborators of Alvin E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alvin E. Davis. Alvin E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Fengxin, Stacey M. Fernandes, & Alvin E. Davis. (2012). The effect of C1 inhibitor on myocardial ischemia and reperfusion injury. Cardiovascular Pathology. 22(1). 75–80. 33 indexed citations

Liu, Dongxu, Fengxin Lu, Gangjian Qin, et al.. (2007). C1 Inhibitor-Mediated Protection from Sepsis. The Journal of Immunology. 179(6). 3966–3972. 46 indexed citations

Rosen, Fred S. & Alvin E. Davis. (2005). Deficiencies of C1 inhibitor. Best Practice & Research Clinical Gastroenterology. 19(2). 251–261. 13 indexed citations

Davis, Alvin E., Shenghe Cai, & Dongxu Liu. (2004). The Biological Role of the C1 Inhibitor in Regulation of Vascular Permeability and Modulation of Inflammation. Advances in immunology. 82. 331–363. 13 indexed citations

Davis, Alvin E.. (2004). Biological effects of C1 inhibitor. Drug News & Perspectives. 17(7). 439–439. 72 indexed citations

Cai, Shenghe & Alvin E. Davis. (2003). Complement Regulatory Protein C1 Inhibitor Binds to Selectins and Interferes with Endothelial-Leukocyte Adhesion. The Journal of Immunology. 171(9). 4786–4791. 76 indexed citations

Liu, Dongxu, et al.. (2003). C1 Inhibitor Prevents Endotoxin Shock Via a Direct Interaction with Lipopolysaccharide. The Journal of Immunology. 171(5). 2594–2601. 63 indexed citations

Scafidi, Jennifer, et al.. (2003). Approaches toward reversal of increased vascular permeability in C1 inhibitor deficient mice. Immunology Letters. 89(2-3). 155–160. 19 indexed citations

MacFarlane, Ryan C., et al.. (2001). C1 Inhibitor: Analysis of the Role of Amino Acid Residues Within the Reactive Center Loop in Target Protease Recognition. The Journal of Immunology. 167(3). 1500–1506. 15 indexed citations

10.

Aulak, Kulwant S., et al.. (1996). Characterization of C1 Inhibitor-Ta. Journal of Biological Chemistry. 271(39). 24307–24312. 30 indexed citations

11.

Donaldson, Virginia H., et al.. (1996). Antibody to C1-inhibitor in a patient receiving C1-inhibitor infusions for treatment of hereditary angioneurotic edema with systemic lupus erythematosus reacts with a normal allotype of residue 458 of C1-inhibitor. Journal of Laboratory and Clinical Medicine. 128(4). 438–443. 11 indexed citations

12.

Bissler, John J., Virginia H. Donaldson, & Alvin E. Davis. (1994). Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edema. Human Genetics. 93(3). 265–269. 22 indexed citations

13.

Davis, Alvin E., Kulwant S. Aulak, Kamyar Zahedi, John J. Bissler, & R. A. Harrison. (1993). [6] C1 Inhibitor. Methods in enzymology on CD-ROM/Methods in enzymology. 223. 97–120. 11 indexed citations

14.

Cicardi, Marco, et al.. (1991). Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema.. Journal of Clinical Investigation. 88(3). 755–759. 24 indexed citations

15.

Kramer, J., et al.. (1991). Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.. Journal of Clinical Investigation. 87(5). 1614–1620. 22 indexed citations

16.

Laclette, Juan Pedro, et al.. (1991). Paramyosin is the Schistosoma mansoni (Trematoda) homologue of antigen B from Taenia solium (Cestoda). Molecular and Biochemical Parasitology. 44(2). 287–295. 68 indexed citations

17.

Strang, Candace, et al.. (1988). Angioedema induced by a peptide derived from complement component C2.. The Journal of Experimental Medicine. 168(5). 1685–1698. 50 indexed citations

18.

Harrison, R. A., et al.. (1988). Structure of C3f, a Small Peptide Specifically Released during Inactivation of the Third Component of Complement. PubMed. 5(1). 27–32. 13 indexed citations

19.

Hall, Robert E., R. Michael Blaese, Alvin E. Davis, et al.. (1982). Cooperative interaction of factor B and other complement components with mononuclear cells in the antibody-independent lysis of xenogeneic erythrocytes.. The Journal of Experimental Medicine. 156(3). 834–843. 30 indexed citations

20.

Groshong, Ted, Sheldon D. Horowitz, Judith C. Lovchik, Alvin E. Davis, & Richard Hong. (1976). Chronic cytomegalovirus infection, immunodeficiency, and monoclonal gammopathy-antigen-driven malignancy?. The Journal of Pediatrics. 88(2). 217–223. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact